Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF JUNE 07, 2024 SAM #8228
SPECIAL NOTICE

A -- Transit Analysis for Shuttle Schedule Optimization

Notice Date

6/5/2024 8:46:16 AM
 

Notice Type

Special Notice
 

NAICS

485113 — Bus and Other Motor Vehicle Transit Systems
 

Contracting Office

FOOD AND DRUG ADMINISTRATION Rockville MD 20841 US
 

ZIP Code

20841
 

Solicitation Number

75F40124R00117
 

Response Due

6/17/2024 9:00:00 AM
 

Archive Date

06/17/2024
 

Point of Contact

Natapol Sirikhan, Phone: 240-402-8031
 

E-Mail Address

Natapol.Sirikhan@fda.hhs.gov
(Natapol.Sirikhan@fda.hhs.gov)
 

Small Business Set-Aside

SBA Total Small Business Set-Aside (FAR 19.5)
 

Description

Notice of Fair Opportunity Small Business Set Aside - After Exclusion of Sources The US Food and Drug� Administration {FDA), Office of Finance Budget Acquisition and Planning, intends to issue a single award� from a fair opportunity competition After Exclusion of Sources; to conduct an analysis of all relevant transit options within the FDA White Oak Campus service area, located at 10903 New Hampshire�Ave, Silver Spring, Maryland 20993; to update and modify FDA Commuter and Circulator Shuttle Bus schedules servicing the White Oak Campus; based on the results of the analysis with the objective of supplementing the services provided by local public transit agencies; and to provide for service where there are gaps in service provided by public transit agencies. The propose this acquisition under the exclusion of sources, is for the Government to solicit and negotiate with identified source only. Interested parties may identify their interests and capabilities to respond to the requirement within seven (7) days after the publication of this notice. A determination by the Government not to compete this proposed acquisition, other than Small Business Set Aside - After Exclusion of Sources, based upon responses to this notice, is solely within the discretion of the Government.� Information received will normally be considered solely for the purpose of determining, not to conduct a set aside competitive requirement. No further solicitation is available. FDA will consider all responses received prior to the closing date of this notice and will use responses in determining, whether it is necessary to use full and open competition for this requirement. Responses shall be emailed to Natapol Sirikhan, Natapol.Sirikhan@fda.hhs.gov, by June 17, 2024, 12:00 PM EST.
 

Web Link

SAM.gov Permalink
(https://sam.gov/opp/108502d51e3e4a719b7be5f25c0c529e/view)
 

Place of Performance

Address: Silver Spring, MD 20903, USA

Zip Code: 20903

Country: USA
 

Record

SN07086643-F 20240607/240605230111 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |